A Dairy Product to Reconstitute Enriched with Bioactive Nutrients Stops Bone Loss in High-Risk Menopausal Women without Pharmacological Treatment
- PMID: 32722015
- PMCID: PMC7468696
- DOI: 10.3390/nu12082203
A Dairy Product to Reconstitute Enriched with Bioactive Nutrients Stops Bone Loss in High-Risk Menopausal Women without Pharmacological Treatment
Abstract
Osteoporosis is a multifactorial disease characterized by the loss of bone mass and deterioration of the internal structure of the bone, increasing the risk of fractures, and is becoming an economic and social problem. The main treatment is pharmacological, however, the population demands other therapies, such as foods with nutrients beneficial to bone health. Seventy-eight healthy menopausal women at risk of osteoporosis or untreated osteopenia were recruited for a randomized, parallel, double-blind clinical trial with two intervention groups: one group consumed a serving a day of the experimental enriched product (experimental group (EG)) and the other group (control group (CG)) consumed the same product without enrichment. The main objective was to compare the effect of consuming a dairy preparation to reconstitute, similar to yogurt when prepared, enriched in calcium, vitamin D, vitamin K, vitamin C, zinc, magnesium, L-leucine and probiotic (Lactobacillus plantarum 3547) on bone metabolism markers for 24 weeks. The EG showed a significantly increased bone mass compared to the CG (0.01 ± 0.03 vs. -0.01 ± 0.03 kg; p < 0.05). In addition, the EG maintained their bone mineral density (BMD) compared to the CG, whose BMD significantly decreased at the end of the study. For biochemical markers, the EG significantly increased the serum levels of the N-terminal propeptide of type I collagen (P1NP) bone formation marker (13.19 ± 25.17 vs. -4.21 ± 15.62 ng/mL; p < 0.05), and decreased the carbo-terminal telopeptide of type I collagen (CTx) bone resorption marker compared to the CG (-0.05 ± 0.19 vs. 0.04 ± 0.14 ng/mL; p < 0.05). On the other hand, the EG exhibited a significantly decreased systolic and diastolic blood pressure compared to the start of the study. Finally, the EG significantly increased their dietary calcium and vitamin D intake compared to the CG. In conclusion, the regular consumption of a dairy product to reconstitute enriched with bioactive nutrients improves bone health markers in menopausal women at risk of osteoporosis without pharmacological treatment.
Keywords: bone mineral density; functional foods; nutrition; osteoporosis; prevention.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Consumption of yogurts fortified in vitamin D and calcium reduces serum parathyroid hormone and markers of bone resorption: a double-blind randomized controlled trial in institutionalized elderly women.J Clin Endocrinol Metab. 2013 Jul;98(7):2915-21. doi: 10.1210/jc.2013-1274. Epub 2013 May 7. J Clin Endocrinol Metab. 2013. PMID: 23653431 Clinical Trial.
-
High-calcium, vitamin D fortified milk is effective in improving bone turnover markers and vitamin D status in healthy postmenopausal Chinese women.Eur J Clin Nutr. 2012 Jul;66(7):856-61. doi: 10.1038/ejcn.2012.54. Epub 2012 May 30. Eur J Clin Nutr. 2012. PMID: 22644348 Clinical Trial.
-
Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study.Nutrients. 2018 Jan 16;10(1):97. doi: 10.3390/nu10010097. Nutrients. 2018. PMID: 29337906 Free PMC article. Clinical Trial.
-
The Utility of Biomarkers in Osteoporosis Management.Mol Diagn Ther. 2017 Aug;21(4):401-418. doi: 10.1007/s40291-017-0272-1. Mol Diagn Ther. 2017. PMID: 28271451 Review.
-
Are Probiotics the New Calcium and Vitamin D for Bone Health?Curr Osteoporos Rep. 2020 Jun;18(3):273-284. doi: 10.1007/s11914-020-00591-6. Curr Osteoporos Rep. 2020. PMID: 32285249 Review.
Cited by
-
Unleashing the potential of Genistein and its derivatives as effective therapeutic agents for breast cancer treatment.Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3321-3343. doi: 10.1007/s00210-024-03579-6. Epub 2024 Nov 16. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39549063 Review.
-
Linking the relation between gut microbiota and glucocorticoid-induced osteoporosis.J Bone Miner Metab. 2023 Mar;41(2):145-162. doi: 10.1007/s00774-023-01415-0. Epub 2023 Mar 13. J Bone Miner Metab. 2023. PMID: 36912997 Free PMC article. Review.
-
A Review on the Molecular Mechanisms of Action of Natural Products in Preventing Bone Diseases.Int J Mol Sci. 2022 Jul 30;23(15):8468. doi: 10.3390/ijms23158468. Int J Mol Sci. 2022. PMID: 35955603 Free PMC article. Review.
-
Effects of Dietary Omega-3 Enrichment on the Chemical Composition and the Pathogenic Microbiota of Ovine Milk.Foods. 2022 Nov 21;11(22):3736. doi: 10.3390/foods11223736. Foods. 2022. PMID: 36429328 Free PMC article.
-
Physical Exercise and Dietary Supplementation in Middle-Aged and Older Women: A Systematic Review.J Clin Med. 2023 Nov 23;12(23):7271. doi: 10.3390/jcm12237271. J Clin Med. 2023. PMID: 38068323 Free PMC article. Review.
References
-
- National Institutes of Health NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, March 7–29, 2000: Highlights of the Conference. South. Med. J. 2001;94:569–573. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources